L Verbist

734 total citations
13 papers, 461 citations indexed

About

L Verbist is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, L Verbist has authored 13 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Infectious Diseases and 3 papers in Pharmacology. Recurrent topics in L Verbist's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Urinary Tract Infections Management (2 papers). L Verbist is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Resistance in Bacteria (3 papers) and Urinary Tract Infections Management (2 papers). L Verbist collaborates with scholars based in Belgium, Rwanda and Vietnam. L Verbist's co-authors include Jan Verhaegen, André Geubel, M. Hautekèete, R Brenard, Jean Henrion, Jacques Rahier, P. Michielsen, Yves Horsmans, Christian Demanet and P Yap and has published in prestigious journals such as Gastroenterology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

L Verbist

13 papers receiving 407 citations

Peers

L Verbist

PHARM

EPIDE

ONCOL

HEPAT

Michael S. Maddux United States

C A Wood United States

K. Sack Germany

Ofir Har‐Noy Israel

J. R. Lowe United Kingdom

Isabelle Seguin Canada

Seonghae Yoon South Korea

Amy Pickard United States

Pierre Comby France

Gurudatt Chandorkar United States

Michael S. Maddux United States

L Verbist

38 ×0.2

PHARM

89 ×0.7

PHARM

88 ×0.8

EPIDE

45 ×0.4

ONCOL

39 ×0.4

HEPAT

Citations per year, relative to L Verbist L Verbist (= 1×) peers Michael S. Maddux

Countries citing papers authored by L Verbist

Since Specialization

Citations

This map shows the geographic impact of L Verbist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Verbist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Verbist more than expected).

Fields of papers citing papers by L Verbist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Verbist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Verbist. The network helps show where L Verbist may publish in the future.

Co-authorship network of co-authors of L Verbist

This figure shows the co-authorship network connecting the top 25 collaborators of L Verbist. A scholar is included among the top collaborators of L Verbist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Verbist. L Verbist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Hautekèete, M., Yves Horsmans, C. Van Waeyenberge, et al.. (1999). HLA association of amoxicillin-clavulanate–induced hepatitis. Gastroenterology. 117(5). 1181–1186. 193 indexed citations

2.

Zaman, Z., et al.. (1998). Disappointing dipstick screening for urinary tract infection in hospital inpatients.. Journal of Clinical Pathology. 51(6). 471–472. 33 indexed citations

3.

Verbist, L, et al.. (1996). Comparative activity of piperacillin/tazobactam against 5625 isolates from hospitalised patients. Journal of Antimicrobial Chemotherapy. 37(2). 285–293. 8 indexed citations

4.

Verbist, L, et al.. (1996). Bacteraemia WithLeptotrichia Buccalis:Report of A Case and Review of the Literature. Acta Clinica Belgica. 51(4). 265–270. 15 indexed citations

5.

Hautekèete, M., R Brenard, Yves Horsmans, et al.. (1995). Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations. Journal of Hepatology. 22(1). 71–77. 78 indexed citations

6.

Wauters, G., et al.. (1995). Evaluation of a new identification system, Crystal Enteric/Non-Fermenter, for gram-negative bacilli. Journal of Clinical Microbiology. 33(4). 845–849. 32 indexed citations

7.

Ende, J Van den, E Van den Enden, Chad K. Brands, et al.. (1995). Diagnosis of amoebic infection of the liver: report of 36 cases.. PubMed. 75(4). 297–303. 11 indexed citations

8.

Declercq, Jean‐Paul, Jan Verhaegen, L Verbist, et al.. (1994). Salmonella typhi osteomyelitis. Archives of Orthopaedic and Trauma Surgery. 113(4). 232–234. 13 indexed citations

9.

Abs, Roger, et al.. (1990). Hypoglycemia owing to inappropriate glucagon secretion treated with a continuous subcutaneous glucagon infusion system. European Journal of Endocrinology. 122(3). 319–322. 6 indexed citations

10.

Bogaerts, J., et al.. (1990). Characterization, in vitro susceptibility, and clinical significance of CDC group HB-5 from Rwanda. Journal of Clinical Microbiology. 28(10). 2196–2199. 4 indexed citations

11.

Peeters, Annelies, Mark Waer, P. Michielsen, L Verbist, & H. Carton. (1989). Listeria monocytogenes meningitis. Clinical Neurology and Neurosurgery. 91(1). 29–36. 10 indexed citations

12.

Verbist, L & Jan Verhaegen. (1981). In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime. Antimicrobial Agents and Chemotherapy. 19(3). 402–406. 40 indexed citations

13.

Verbist, L & Jan Verhaegen. (1981). In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin. Antimicrobial Agents and Chemotherapy. 19(2). 222–225. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact